185 related articles for article (PubMed ID: 34739255)
1. Interface-Engineered Paclitaxel-Based Hollow Mesoporous Organosilica Nanoplatforms for Photothermal-Enhanced Chemotherapy of Tumor.
Qian C; Al-Hamyari B; Tang X; Hou B; Yang S; Zhang G; Lv H; Yang Z; Wang Z; Shi Y
Mol Pharm; 2021 Dec; 18(12):4531-4542. PubMed ID: 34739255
[TBL] [Abstract][Full Text] [Related]
2. Merging metal organic framework with hollow organosilica nanoparticles as a versatile nanoplatform for cancer theranostics.
Chen L; Zhang J; Zhou X; Yang S; Zhang Q; Wang W; You Z; Peng C; He C
Acta Biomater; 2019 Mar; 86():406-415. PubMed ID: 30625415
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional Mesoporous Polydopamine With Hydrophobic Paclitaxel For Photoacoustic Imaging-Guided Chemo-Photothermal Synergistic Therapy.
Zhang L; Yang P; Guo R; Sun J; Xie R; Yang W
Int J Nanomedicine; 2019; 14():8647-8663. PubMed ID: 31806962
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable nanotheranostics with hyperthermia-induced bubble ability for ultrasound imaging-guided chemo-photothermal therapy.
Xu C; Gao F; Wu J; Niu S; Li F; Jin L; Shi Q; Du L
Int J Nanomedicine; 2019; 14():7141-7153. PubMed ID: 31564870
[TBL] [Abstract][Full Text] [Related]
5. Fabrication of multifunctional triple-responsive platform based on CuS-capped periodic mesoporous organosilica nanoparticles for chemo-photothermal therapy.
Cheng X; Li D; Lin A; Xu J; Wu L; Gu H; Huang Z; Liu J; Zhang Y; Yin X
Int J Nanomedicine; 2018; 13():3661-3677. PubMed ID: 29983561
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable hollow mesoporous organosilica nanotheranostics (HMONs) as a versatile platform for multimodal imaging and phototherapeutic-triggered endolysosomal disruption in ovarian cancer.
Li P; Lin B; Chen Z; Liu P; Liu J; Li W; Liu P; Guo Z; Chen C
Drug Deliv; 2022 Dec; 29(1):161-173. PubMed ID: 34967262
[TBL] [Abstract][Full Text] [Related]
7. Acidity/Reducibility Dual-Responsive Hollow Mesoporous Organosilica Nanoplatforms for Tumor-Specific Self-Assembly and Synergistic Therapy.
Tang W; Fan W; Wang Z; Zhang W; Zhou S; Liu Y; Yang Z; Shao E; Zhang G; Jacobson O; Shan L; Tian R; Cheng S; Lin L; Dai Y; Shen Z; Niu G; Xie J; Chen X
ACS Nano; 2018 Dec; 12(12):12269-12283. PubMed ID: 30418749
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel/IR1061-Co-Loaded Protein Nanoparticle for Tumor-Targeted and pH/NIR-II-Triggered Synergistic Photothermal-Chemotherapy.
He L; Qing F; Li M; Lan D
Int J Nanomedicine; 2020; 15():2337-2349. PubMed ID: 32308385
[TBL] [Abstract][Full Text] [Related]
9. Chemodrug-Gated Biodegradable Hollow Mesoporous Organosilica Nanotheranostics for Multimodal Imaging-Guided Low-Temperature Photothermal Therapy/Chemotherapy of Cancer.
Wu J; Bremner DH; Niu S; Shi M; Wang H; Tang R; Zhu LM
ACS Appl Mater Interfaces; 2018 Dec; 10(49):42115-42126. PubMed ID: 30462492
[TBL] [Abstract][Full Text] [Related]
10. Photo-responsive degradable hollow mesoporous organosilica nanoplatforms for drug delivery.
Fan J; Zhang Z; Wang Y; Lin S; Yang S
J Nanobiotechnology; 2020 Jun; 18(1):91. PubMed ID: 32539777
[TBL] [Abstract][Full Text] [Related]
11. Synergistic Chemo-Photothermal Therapy of Breast Cancer by Mesenchymal Stem Cell-Encapsulated Yolk-Shell GNR@HPMO-PTX Nanospheres.
Wu J; Liu Y; Tang Y; Wang S; Wang C; Li Y; Su X; Tian J; Tian Y; Pan J; Su Y; Zhu H; Teng Z; Lu G
ACS Appl Mater Interfaces; 2016 Jul; 8(28):17927-35. PubMed ID: 27356586
[TBL] [Abstract][Full Text] [Related]
12. A Tumor Microenvironment-Responsive Biodegradable Mesoporous Nanosystem for Anti-Inflammation and Cancer Theranostics.
Wu J; Niu S; Bremner DH; Nie W; Fu Z; Li D; Zhu LM
Adv Healthc Mater; 2020 Jan; 9(2):e1901307. PubMed ID: 31814332
[TBL] [Abstract][Full Text] [Related]
13. Near-infrared light triggered drug delivery system for higher efficacy of combined chemo-photothermal treatment.
Chen Y; Li H; Deng Y; Sun H; Ke X; Ci T
Acta Biomater; 2017 Mar; 51():374-392. PubMed ID: 28088668
[TBL] [Abstract][Full Text] [Related]
14. Triple stimuli-responsive ZnO quantum dots-conjugated hollow mesoporous carbon nanoplatform for NIR-induced dual model antitumor therapy.
Feng S; Mao Y; Wang X; Zhou M; Lu H; Zhao Q; Wang S
J Colloid Interface Sci; 2020 Feb; 559():51-64. PubMed ID: 31610305
[TBL] [Abstract][Full Text] [Related]
15. Aerosol technique-based carbon-encapsulated hollow mesoporous silica nanoparticles for synergistic chemo-photothermal therapy.
Gautam M; Thapa RK; Poudel BK; Gupta B; Ruttala HB; Nguyen HT; Soe ZC; Ou W; Poudel K; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2019 Apr; 88():448-461. PubMed ID: 30818051
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of nanoparticle and molecular drug by hollow mesoporous organosilica for tumor-activated and photothermal-augmented chemotherapy of breast cancer.
Zhang H; Song F; Dong C; Yu L; Chang C; Chen Y
J Nanobiotechnology; 2021 Sep; 19(1):290. PubMed ID: 34579711
[TBL] [Abstract][Full Text] [Related]
17. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
18. "Navigate-dock-activate" anti-tumor strategy: Tumor micromilieu charge-switchable, hierarchically activated nanoplatform with ultrarapid tumor-tropic accumulation for trackable photothermal/chemotherapy.
Cherukula K; Uthaman S; Park IK
Theranostics; 2019; 9(9):2505-2525. PubMed ID: 31131050
[TBL] [Abstract][Full Text] [Related]
19. Bubble-generating polymersomes loaded with both indocyanine green and doxorubicin for effective chemotherapy combined with photothermal therapy.
Zhu D; Fan F; Huang C; Zhang Z; Qin Y; Lu L; Wang H; Jin X; Zhao H; Yang H; Zhang C; Yang J; Liu Z; Sun H; Leng X; Kong D; Zhang L
Acta Biomater; 2018 Jul; 75():386-397. PubMed ID: 29793073
[TBL] [Abstract][Full Text] [Related]
20. A Multifunctional Biodegradable Nanocomposite for Cancer Theranostics.
Wu J; Williams GR; Niu S; Gao F; Tang R; Zhu LM
Adv Sci (Weinh); 2019 Jul; 6(14):1802001. PubMed ID: 31380200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
